Here, we found that pretreatment with apigenin sensitizes established human lung cancer cell lines to TRAIL-induced apoptosis (Figs. 1 and S1), in agreement with previous studies administering TRAIL and apigenin concomitantly in lung25, leukemia24, and prostate cancer cell lines26. Here, TNFSF10 is linked to lung carcinoma.